Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical (LFCR) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Lifecore Biomedical (LFCR) over the last 5 years, with May 2025 value amounting to $1.9 million.

  • Lifecore Biomedical's Accumulated Depreciation & Amortization fell 4.97% to $1.9 million in Q2 2025 from the same period last year, while for May 2025 it was $8.0 million, marking a year-over-year decrease of 1.81%. This contributed to the annual value of $8.0 million for FY2025, which is 0.92% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's Accumulated Depreciation & Amortization is $1.9 million, which was down 7.80% from $2.1 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Accumulated Depreciation & Amortization ranged from a high of $5.9 million in Q4 2021 and a low of $1.9 million during Q2 2025.
  • Over the past 3 years, Lifecore Biomedical's median Accumulated Depreciation & Amortization value was $2.0 million (recorded in 2024), while the average stood at $2.2 million.
  • The largest annual percentage gain for Lifecore Biomedical's Accumulated Depreciation & Amortization in the last 5 years was 25.51% (2021), contrasted with its biggest fall of 94.67% (2021).
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Accumulated Depreciation & Amortization stood at $5.9 million in 2021, then crashed by 50.41% to $2.9 million in 2022, then tumbled by 32.41% to $2.0 million in 2023, then climbed by 2.87% to $2.0 million in 2024, then dropped by 4.97% to $1.9 million in 2025.
  • Its Accumulated Depreciation & Amortization was $1.9 million in Q2 2025, compared to $2.1 million in Q1 2025 and $2.0 million in Q4 2024.